Association Between Metabolic Dysfunction-Associated Fatty Liver Disease and Cardiovascular Risk in Patients With Rheumatoid Arthritis: A Cross-Sectional Study of Chinese Cohort

BackgroundThe nomenclature from non-alcoholic fatty liver disease (NAFLD) to metabolic dysfunction-associated fatty liver disease (MAFLD) is considered to identify more cardiovascular disease (CVD) risks in the general population. Patients with rheumatoid arthritis (RA) carry an excess risk for CVD....

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Yao-Wei Zou, Qian-Hua Li, Jing-Wei Gao, Jie Pan, Jian-Da Ma, Le-Feng Chen, Jian-Zi Lin, Ying-Qian Mo, Xue-Pei Zhang, Pin-Ming Liu, Lie Dai
פורמט: Artigo
שפה:Inglês
יצא לאור: Frontiers Media S.A. 2022-05-01
סדרה:Frontiers in Cardiovascular Medicine
נושאים:
cardiovascular disease
rheumatoid arthritis
metabolic dysfunction-associated fatty liver disease
non-alcoholic fatty liver disease
inflammation
גישה מקוונת:https://www.frontiersin.org/articles/10.3389/fcvm.2022.884636/full
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים